Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/5321
Title: Cardioprotective effects of magnesium valproate in type 2 diabetes mellitu
Authors: Raghunathan, Suchi
Keywords: IPFP0129
hyperglycaemia
Issue Date: 2014
Publisher: Elsevier
Series/Report no.: IPFP0129;
Abstract: Wehaveevaluatedtheeffectofmagnesiumvalproate(210mg/kg/day,p.o.)intype2diabetesinduced cardiovascularcomplicationsinducedbystreptozotocin(STZ,90mg/kg,i.p.)inneonatalwistarrats.Various biochemical,cardiovascularandhemodynamicparametersweremeasuredattheendof8weeksof treatment.STZproducedsignificanthyperglycaemia,hypoinsulinemiaanddyslipidemia,whichwas preventedbymagnesiumvalproatetreatment.STZproducedincreaseinCreatinineKinase,C-reactive proteinandlactatedehydrogenaselevelsandtreatmentwithmagnesiumvalproateproducedreductionin these levels.STZproducedincreaseincardiacandLVhypertrophyindex,LV/RVratio,LVcollagendeposition andLVcardiomyocytediameterwhichweredecreasedbymagnesiumvalproatetreatment.Magnesium valproatealsopreventedSTZinducedhemodynamicalterationsandoxidativestress.Theseresultswere further supportedbyhistopathologicalstudiesinwhichmagnesiumvalproateshowedmarkedreductionin fibrosisandcardiac fiber disarray.Inconclusion,ourdatasuggeststhatmagnesiumvalproateisbeneficial as ananti-diabeticagentintype-2diabetesmellitusandalsopreventsitscardiaccomplications.
Description: European Journal of Pharmacology 728 (2014) 128–134
URI: http://hdl.handle.net/123456789/5321
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0129.pdfIPFP01294.45 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.